PPR-107 - Pharmacy professionals' perception of best practices and challenges in fulfilling the national association of pharmacy regulatory authorities model standards for pharmacy compounding in Canada

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-107
• By: HO, Certina (University of Toronto, Canada)
• Co-author(s): Dr Certina Ho, Executive Committee Member (University of Toronto, Toronto, Canada)
  Mr. Vincent Huynh (University of Toronto, Toronto, Canada)
  Ms. Yu Xie (Jenna) Zhang (University of Toronto, Toronto, Canada)
  Ms. Sheena Ye (University of Toronto, Toronto, Canada)
  Ms. Camryn Kabir-Bahk (University of Toronto, Toronto, Canada)
  Dr. Anna Nguyen (University of Toronto, Toronto, Canada)
  Dr. Justin Lee (University of Toronto, Toronto, Canada)
  Ms. Fatima Hashemi-Sabet (University of Toronto, Toronto, Canada)
  
• Abstract:

  Introduction: Unlike manufactured drugs, compounded medications do not require quality testing through Health Canada. Consequently, concerns were raised about potential gaps in regulations and standards for quality control, assurance, and formulation consistency of compounded products. Recognizing this, the National Association of Pharmacy..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login